Vitamin K may affect inflammation, oxidative stress and proliferation, but prospective evidence for lung cancer remains limited. We examined dietary vitamin K intake and incident lung cancer among 55,031 cancer-free participants from the Danish Diet, Cancer and Health (DDCH) cohort and 185,123 from the UK Biobank (UKB). Vitamin K₁ and K₂ intakes were estimated from food frequency questionnaires in the DDCH cohort and 24-hour dietary recalls in UKB using cohort-specific food composition databases. Incident lung cancer was ascertained through national cancer registries. Multivariable-adjusted Cox proportional hazards models were fitted within each cohort with estimates pooled using fixed-effects meta-analysis. Additionally, analyses were stratified by smoking status and lung cancer polygenic risk scores. During follow-up, 1,938 lung cancer cases occurred in the DDCH and 1,145 in UKB, mostly among ever smokers. Higher vitamin K₁ intake was associated with lower lung cancer incidence in pooled analyses (Hazard ratio, HRQ5vsQ1: 0.87, 95% CI: 0.77–0.97), particularly among ever smokers (HR 0.82, 95% CI 0.73–0.92), but not never smokers (HR 1.05, 95% CI 0.74–1.49). Vitamin K₂ intake was not associated with lung cancer. Absolute risk modelling suggested the largest 20-year risk reductions among current smokers. Among UKB ever smokers, inverse associations for moderate vitamin K₁ intake were most evident in individuals with high genetic risk, with estimates in other strata closer to null. These findings suggest a potential role of vitamin K₁-rich foods, such as green leafy vegetables, in smoking-related lung cancer prevention, while reinforcing smoking cessation as the primary prevention strategy.